Posted by Michael Wonder on 04 Mar 2020
Changes in list prices, net prices, and discounts for branded drugs in the US, 2007-2018
3 March 2020 - Using 2007-2018 net pricing data on branded pharmaceutical products in the US, list prices increased by 159% and net prices increased by 60%.
Discounts increased from 40% in 2007 to 76% in 2018 in Medicaid and increased from 23% to 51% in other payers, offsetting 62% of increases in list prices for drugs.
Although discounts partially offset list price increases of branded products from 2007 to 2018, there was still a substantial increase in net prices over this period.
